Stock listing
NASDAQ:ISPC iSpecimen Inc. Stock
Home listing (NASDAQ) of iSpecimen Inc.
Follow iSpecimen Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ISPC
$0.456 USD -0.077 (-14.4%)
Close on Nov 20, 2026
- Day range
- $0.432 – $0.531 USDNov 20, 2026
- Volume
- 150,786 sharesNov 20, 2026
- Market cap
- $2.64M USDAt the close on Nov 20, 2026 · price × 5.79M shares outstanding
- 52-week range
- $0.432 – $27.440 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1.09M USDMedian day 103,165 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ISPC · Home | $0.456 USD | -0.077 (-14.4%) | 150,786 | $0.531 | $0.531 | $0.432 | $0.533 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ISPC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.456 | -0.077 | -14.4% | $0.531 | $0.531 | $0.432 | 150,786 | |
| $0.533 | -0.063 | -10.6% | $0.567 | $0.567 | $0.527 | 39,102 | |
| $0.596 | -0.009 | -1.5% | $0.590 | $0.596 | $0.559 | 41,944 | |
| $0.605 | -0.054 | -8.2% | $0.640 | $0.640 | $0.570 | 64,769 | |
| $0.659 | -0.038 | -5.4% | $0.681 | $0.681 | $0.630 | 113,270 | |
| $0.697 | -0.013 | -1.8% | $0.714 | $0.714 | $0.679 | 28,617 | |
| $0.709 | -0.028 | -3.8% | $0.738 | $0.738 | $0.641 | 95,565 | |
| $0.738 | -0.052 | -6.6% | $0.791 | $0.791 | $0.713 | 67,946 | |
| $0.790 | -0.024 | -3.0% | $0.801 | $0.801 | $0.770 | 54,707 | |
| $0.814 | +0.006 | +0.8% | $0.819 | $0.838 | $0.785 | 237,303 | |
| $0.808 | -0.035 | -4.2% | $0.830 | $0.847 | $0.760 | 211,656 | |
| $0.843 | +0.053 | +6.7% | $0.830 | $0.897 | $0.786 | 166,926 | |
| $0.790 | -0.043 | -5.1% | $0.824 | $0.939 | $0.772 | 490,612 | |
| $0.832 | +0.007 | +0.8% | $0.826 | $0.840 | $0.754 | 103,165 | |
| $0.826 | +0.033 | +4.2% | $0.830 | $0.870 | $0.753 | 517,843 | |
| $0.792 | -0.082 | -9.3% | $0.841 | $0.940 | $0.792 | 2,162,762 | |
| $0.874 | +0.002 | +0.2% | $0.840 | $0.874 | $0.840 | 30,448 | |
| $0.872 | +0.032 | +3.8% | $0.834 | $0.891 | $0.832 | 47,836 | |
| $0.840 | +0.023 | +2.8% | $0.802 | $0.870 | $0.791 | 59,922 | |
| $0.817 | -0.016 | -1.9% | $0.800 | $0.830 | $0.789 | 39,900 | |
| $0.833 | -0.060 | -6.7% | $0.830 | $0.857 | $0.813 | 70,000 | |
| $0.893 | -0.067 | -7.0% | $0.926 | $0.950 | $0.875 | 71,900 | |
| $0.960 | +0.050 | +5.5% | $0.940 | $0.995 | $0.890 | 233,400 | |
| $0.910 | -0.007 | -0.8% | $0.917 | $0.959 | $0.900 | 827,100 | |
| $0.917 | -0.113 | -11.0% | $1.020 | $1.020 | $0.910 | 47,500 | |
| $1.030 | +0.010 | +1.0% | $0.980 | $1.050 | $0.970 | 100,000 | |
| $1.020 | -0.060 | -5.6% | $1.070 | $1.070 | $1.020 | 65,700 | |
| $1.080 | 0.000 | 0.0% | $1.070 | $1.100 | $1.031 | 69,200 | |
| $1.080 | -0.050 | -4.4% | $1.120 | $1.132 | $1.055 | 44,900 | |
| $1.130 | +0.040 | +3.7% | $1.100 | $1.150 | $1.100 | 71,100 | |
| $1.090 | -0.010 | -0.9% | $1.090 | $1.130 | $1.070 | 70,800 | |
| $1.100 | +0.030 | +2.8% | $1.070 | $1.110 | $1.050 | 51,400 | |
| $1.070 | +0.020 | +1.9% | $1.040 | $1.100 | $1.030 | 101,000 | |
| $1.050 | -0.030 | -2.8% | $1.080 | $1.090 | $1.020 | 124,800 | |
| $1.080 | -0.060 | -5.3% | $1.150 | $1.150 | $1.040 | 147,600 | |
| $1.140 | -0.040 | -3.4% | $1.170 | $1.190 | $1.140 | 25,700 | |
| $1.180 | -0.050 | -4.1% | $1.200 | $1.240 | $1.180 | 59,900 | |
| $1.230 | +0.020 | +1.7% | $1.200 | $1.250 | $1.150 | 125,900 | |
| $1.210 | -0.050 | -4.0% | $1.210 | $1.330 | $1.175 | 444,200 | |
| $1.260 | +0.010 | +0.8% | $1.300 | $1.300 | $1.180 | 534,000 | |
| $1.250 | +0.040 | +3.3% | $1.240 | $1.280 | $1.220 | 4,575,500 | |
| $1.210 | -0.040 | -3.2% | $1.290 | $1.290 | $1.210 | 93,100 | |
| $1.250 | -0.070 | -5.3% | $1.310 | $1.320 | $1.245 | 104,900 | |
| $1.320 | -0.010 | -0.8% | $1.360 | $1.380 | $1.320 | 135,500 | |
| $1.330 | -0.020 | -1.5% | $1.350 | $1.390 | $1.330 | 55,100 | |
| $1.350 | -0.020 | -1.5% | $1.350 | $1.410 | $1.300 | 228,500 | |
| $1.370 | +0.040 | +3.0% | $1.290 | $1.430 | $1.250 | 216,900 | |
| $1.330 | -0.140 | -9.5% | $1.450 | $1.450 | $1.320 | 211,300 | |
| $1.470 | 0.000 | 0.0% | $1.450 | $1.500 | $1.430 | 168,700 | |
| $1.470 | -0.030 | -2.0% | $1.500 | $1.520 | $1.430 | 180,000 | |
| $1.500 | -0.050 | -3.2% | $1.420 | $1.590 | $1.380 | 533,000 | |
| $1.550 | -0.040 | -2.5% | $1.600 | $1.600 | $1.480 | 920,900 | |
| $1.590 | +0.050 | +3.2% | $1.905 | $1.940 | $1.550 | 14,179,900 | |
| $1.540 | 0.000 | 0.0% | $1.530 | $1.570 | $1.510 | 6,591,800 | |
| $1.540 | +0.050 | +3.4% | $1.480 | $1.566 | $1.480 | 30,100 | |
| $1.490 | -0.010 | -0.7% | $1.480 | $1.520 | $1.460 | 56,600 | |
| $1.500 | -0.040 | -2.6% | $1.550 | $1.570 | $1.480 | 52,000 | |
| $1.540 | 0.000 | 0.0% | $1.520 | $1.590 | $1.510 | 60,100 | |
| $1.540 | -0.060 | -3.8% | $1.580 | $1.610 | $1.510 | 87,900 | |
| $1.600 | -0.040 | -2.4% | $1.620 | $1.650 | $1.550 | 62,900 | |
| $1.640 | +0.040 | +2.5% | $1.600 | $1.670 | $1.565 | 230,100 | |
| $1.600 | +0.030 | +1.9% | $1.570 | $1.610 | $1.400 | 274,800 | |
| $1.570 | -0.120 | -7.1% | $1.670 | $1.670 | $1.530 | 247,100 | |
| $1.690 | -0.580 | -25.6% | $1.875 | $1.950 | $1.565 | 1,546,600 | |
| $2.270 | -0.110 | -4.6% | $2.440 | $2.590 | $2.200 | 7,437,200 |
Splits
2 splits since 2024 · NASDAQ:ISPC · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-40 | Consolidation | |
| 1-for-20 | Consolidation |
- Ticker
- NASDAQ:ISPC
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news
iSpecimen Reports 129% Year-Over-Year Increase in Third Quarter Revenue; Highlights Completed Orders for Federal Government and the Centers for Disease Control and Prevention (CDC)
Nov 19, 2026
Closed $0.456 (-14.4%) on Nov 20, 2026
iSpecimen Announces 1-for-6 Reverse Stock Split
Nov 19, 2026
Closed $0.456 (-14.4%) on Nov 20, 2026
iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products
Nov 5, 2026
Closed $0.814 (+0.8%) on Nov 6, 2026
iSpecimen Offers Next-Day Healthy Donor Blood and Launches Development of AI Agent
Oct 29, 2026
Closed $0.826 (+4.2%) on Oct 30, 2026
iSpecimen Supports Hospital Validation of New Chemistry Analyzer
Sep 29, 2026
Closed $1.23 (+1.7%) on Sep 29, 2026
ISpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
Aug 6, 2026
Closed $2.20 (+14.6%) on Aug 6, 2026
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
May 12, 2026
Closed $4.54 (-10.1%) on May 12, 2026
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
May 8, 2026
Closed $5.05 (-1.4%) on May 11, 2026
ISpecimen Announces 1-for-40 Reverse Stock Split
Apr 27, 2026
Closed $4.92 (-5.4%) on Apr 27, 2026
iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time
Apr 9, 2026
Closed $5.12 (-1.5%) on Apr 10, 2026
iSpecimen Inc. on 6ix
- News releases
- 16 in the last 12 months · 84 in all · newest Nov 19, 2026 · oldest 2021
- Calls
- 11 calls with a replay · 11 with a transcript · latest Aug 6, 2024
- Decks
- 13 decks · latest August 2024
Where iSpecimen Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ISPC · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ISPC | BOATS | United States | USD |
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$2.69M USD
- P/E
- Loss
- EV/sales
- −4.5×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 0.7×
- Gross margin
- −75.4%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.1×
- Beta vs S&P 500
- 1.70
Team and board
Officers
| Officer | Role |
|---|---|
| Robert Lim | Chief Executive Officer |
Board
| Director | Role |
|---|---|
| Avtar Dhaliwal | Board Member |
| Katharyn Field | Board Member |
Events
Calls
| Call | When | Status |
|---|---|---|
| iSpecimen (NASDAQ:ISPC) Q2 2024 Earnings Call | Tue, Aug 06, 2024 · 8:30 AM ET | Replay |
| iSpecimen (NASDAQ:ISPC) Q1 2024 Earnings Call | Tue, May 07, 2024 · 8:30 AM ET | Replay |
| iSpecimen (NASDAQ:ISPC) Q4 2023 Earnings Call | Thu, Mar 14, 2024 · 8:30 AM ET | Replay |
| iSpecimen (NASDAQ:ISPC) Q3 2023 Earnings Call | Thu, Nov 02, 2023 · 8:30 AM ET | Replay |
| iSpecimen (NASDAQ:ISPC) Q2 2023 Earnings Call | Wed, Aug 02, 2023 · 8:30 AM ET | Replay |
| iSpecimen (NASDAQ:ISPC) Q1 2023 Earnings Call | Thu, May 04, 2023 · 8:30 AM ET | Replay |
| iSpecimen (NASDAQ:ISPC) Q4 2022 Earnings Call | Tue, Mar 14, 2023 · 8:30 AM ET | Replay |
| iSpecimen (NASDAQ:ISPC) Q3 2022 Earnings Call | Tue, Nov 08, 2022 · 8:30 AM ET | Replay |
| iSpecimen (NASDAQ:ISPC) Q1 2022 Earnings Call | Tue, May 10, 2022 · 8:30 AM ET | Replay |
| iSpecimen (NASDAQ:ISPC) Q4 2021 Earnings Call | Thu, Feb 17, 2022 · 8:30 AM ET | Replay |
All 11 calls
| Call | When | Status |
|---|---|---|
| iSpecimen (NASDAQ:ISPC) Q2 2021 Earnings Call | Tue, Aug 10, 2021 · 8:30 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 17, 2026 | −11.9% |
| Q2 2026 | Aug 14, 2026 | −6.5% |
| Q1 2026 | May 29, 2026 | +0.6% |
| Q4 2025 | Mar 12, 2026 | +18.3% |
| Q3 2025 | Nov 17, 2025 | −11.8% |
| Q2 2025 | Aug 14, 2025 | +1.7% |
| Q1 2025 | May 19, 2025 | +4.0% |
| Q3 2024 | Oct 31, 2024 | +0.5% |
| Q2 2024 | Aug 6, 2024 · Before open | +4.6% |
| Q1 2024 | May 7, 2024 · Before open | +8.0% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Mar 13, 2024 · After close | −21.7% |
| Q3 2023 | Nov 2, 2023 · Before open | −5.6% |
| Q2 2023 | Aug 2, 2023 · Before open | −9.9% |
| Q1 2023 | May 4, 2023 · Before open | −3.5% |
| Q4 2022 | Mar 14, 2023 · Before open | −3.0% |
| Q3 2022 | Nov 8, 2022 · Before open | −3.7% |
| Q2 2022 | Aug 4, 2022 · Before open | −13.9% |
| Q1 2022 | May 10, 2022 · Before open | −6.0% |
| Q4 2021 | Feb 17, 2022 · Before open | −6.9% |
| Quarter to Sep 30, 2021 | Nov 4, 2021 · Before open | −14.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2024) | Investor deck | 28 slides | August 2024 |
| Investor Presentation (May 2024) | Investor deck | 31 slides | May 7, 2024 |
| Investor Presentation (March 2024) | Investor deck | 31 slides | Mar 14, 2024 |
| Investor Presentation (November 2023) | Investor deck | 32 slides | Nov 2, 2023 |
| Investor Presentation (August 2023) | Investor deck | 32 slides | Aug 2, 2023 |
| Investor Presentation (May 2023) | Investor deck | 29 slides | May 4, 2023 |
| Investor Presentation (March 2023) | Investor deck | 29 slides | Mar 14, 2023 |
| Investor Presentation (November 2022) | Investor deck | 29 slides | Nov 8, 2022 |
| Investor Presentation (August 2022) | Investor deck | 29 slides | Aug 4, 2022 |
| Investor Presentation (May 2022) | Investor deck | 29 slides | May 10, 2022 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (February 2022) | Investor deck | 28 slides | Feb 17, 2022 |
| Investor Presentation (November 2021) | Investor deck | 28 slides | Nov 4, 2021 |
| IPO Roadshow (May 2021) | IPO roadshow | 31 slides | May 28, 2021 |
Financings
| Raise | Date |
|---|---|
| Public offering of common stock and/or pre-funded warrants Announced: about US$5M · US$1.3 a share · E.F. Hutton & Co. Dealers: E.F. Hutton & Co. (lead) Use of proceeds: Repaying outstanding liabilities, potential acquisitions or investments, marketing and advertising, and working capital | Aug 6, 2026 |
| Private placement of series C Convertible Preferred Stock Announced: about US$5.5M · US$800 a share · E.F. Hutton & Co. Dealers: E.F. Hutton & Co. (lead) Use of proceeds: Marketing, working capital and general corporate purposes | Dec 30, 2025 |
| Private placement of shares of common stock (or pre-funded warrants) Closed: US$1.75M raised · US$1.122 a share · WestPark Capital, Inc. Dealers: WestPark Capital, Inc. (lead) Use of proceeds: $500,000 for marketing and advertising services by IR Agency LLC; remainder for working capital and general corporate purposes | Aug 4, 2025 |
| Public offering of shares of common stock (or pre-funded warrants) Closed: US$4M in the latest tranche · US$0.7 a share · WestPark Capital, Inc. Dealers: WestPark Capital, Inc. (lead) Use of proceeds: $1.5M for marketing and advertising by IR Agency LLC, $1M initial milestone payment to Sales Stack Solutions Corp., rest for working capital and general purposes | Jul 28, 2025 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Priced at US$8.00 a share on Jun 16, 2021.
- Price
- US$8.00 a share
- Shares offered
- 2,250,000 shares of common stock
- Offering size
- US$18 million
- Underwriters' option
- Up to 337,500 more shares
- Listing
- ISPC on the Nasdaq Capital Market
- Underwriter
- ThinkEquity
- Shares delivered
- On or about Jun 21, 2021
Steps
| Step | When |
|---|---|
| Filed publicly | Nov 19, 2020 |
| Amended 6 times | Newest May 27, 2021 |
| Shares registered with an exchange | Jun 14, 2021 |
| Declared effective by the SEC | Jun 16, 2021 |
| Final prospectus, with the price | Jun 21, 2021 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jun 21, 2021 |
| EFFECT · Notice that a registration is effective | Jun 16, 2021 |
| CERT · Exchange's certificate of listing | Jun 16, 2021 |
| 8-A12B · Registration of shares for listing on an exchange | Jun 14, 2021 |
| CORRESP · Letter to the SEC | Jun 14, 2021 |
| CORRESP · Letter to the SEC | Jun 14, 2021 |
| FWP · Free writing prospectus | May 28, 2021 |
| S-1/A · Registration statement, amended | May 27, 2021 |
| S-1/A · Registration statement, amended | May 13, 2021 |
| CORRESP · Letter to the SEC | Apr 27, 2021 |
All 22 filings
| Filing | Filed |
|---|---|
| S-1/A · Registration statement, amended | Apr 27, 2021 |
| UPLOAD · Letter from the SEC | Apr 26, 2021 |
| CORRESP · Letter to the SEC | Apr 2, 2021 |
| S-1/A · Registration statement, amended | Apr 2, 2021 |
| UPLOAD · Letter from the SEC | Feb 1, 2021 |
| CORRESP · Letter to the SEC | Jan 20, 2021 |
| S-1/A · Registration statement, amended | Jan 20, 2021 |
| UPLOAD · Letter from the SEC | Jan 15, 2021 |
| CORRESP · Letter to the SEC | Dec 31, 2020 |
| S-1/A · Registration statement, amended | Dec 31, 2020 |
| UPLOAD · Letter from the SEC | Dec 14, 2020 |
| S-1 · Registration statement | Nov 19, 2020 |
Open IPO · From the cover of the final prospectus (424B4) filed Jun 21, 2021
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.93M | 9.29M | 9.93M | 10.4M | 11.1M | 8.18M | 4.30M | 4.39M |
| Cost of revenue | 1.71M | 5.11M | 4.77M | 4.76M | 5.25M | 3.59M | 2.13M | 2.36M |
| Gross profit | 24.1K | 3.99M | 5.11M | 5.65M | 5.89M | 4.60M | 2.17M | 2.03M |
| Research and development | 2.16M | 1.49M | 1.62M | 1.47M | 879.2K | 319.2K | 993.3K | 1.21M |
| Selling, general and administrative | 4.30M | 7.70M | 7.72M | 8.93M | 6.98M | 3.26M | 2.85M | 2.19M |
| Operating income | -8.98M | -12.7M | -11.2M | -10.2M | -5.93M | -2.41M | -3.88M | -3.36M |
| Depreciation and amortization | 1.73M | 2.29M | 2.12M | 22.4K | 45.4K | 44.8K | 635.0K | 469.2K |
| EBITDA | -7.25M | -10.4M | -9.05M | -10.2M | -5.88M | -2.36M | -3.25M | -2.89M |
| Interest expense | 1.95K | 173.8K | 16.0K | 239.0K | 2.10M | 2.10M | 1.72M | 1.21M |
| Income before tax | -10.5M | -12.5M | -11.1M | -10.2M | -8.96M | -4.65M | -4.88M | -5.47M |
| Income tax | 3 | 0 | 0 | 0 | -157.0K | -127.0K | ||
| Net income | -10.5M | -12.5M | -11.1M | -10.2M | -8.96M | -4.65M | -4.73M | -5.35M |
| Earnings per share, basic | -2.28 | -17.58 | -24.55 | -1.16 | -2.09 | -4.97 | -575.98 | -651.52 |
| Earnings per share, diluted | -2.28 | -17.58 | -24.55 | -1.16 | -2.09 | -4.97 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6.88M | 1.88M | 2.34M | 15.3M | 27.7M | 695.9K | 53.9K | 1.13M |
| Short-term investments | 0 | 2.66M | 0 | |||||
| Receivables | 48.3K | 1.44M | 728.4K | 1.60M | 3.00M | 1.53M | 1.39M | 1.03M |
| Inventory | 0 | 45.1K | 1 | -3.00M | 54.9K | 47.3K | ||
| Current assets | 6.95M | 3.59M | 8.24M | 19.7M | 32.9M | 3.47M | 1.58M | 2.30M |
| Property, plant and equipment | 25.5K | 93.6K | 127.8K | 225.9K | 32.8K | 75.6K | 119.9K | 149.1K |
| Total assets | 9.53M | 9.35M | 15.8M | 24.6M | 35.7M | 6.21M | 4.21M | 4.04M |
| Accounts payable | 5.36M | 4.20M | 3.93M | 2.46M | 832.7K | 1.79M | 737.8K | 696.9K |
| Current liabilities | 6.23M | 5.77M | 6.05M | 4.28M | 2.51M | 22.1M | 15.8M | 11.3M |
| Long-term debt | 3.42M | 178.9K | ||||||
| Total debt | 268.8K | 312.2K | 196.2K | 185.8K | 3.42M | 12.8M | 10.6M | 6.97M |
| Total liabilities | 6.44M | 6.04M | 6.08M | 4.31M | 5.93M | 22.3M | 26.9M | 22.5M |
| Shareholders' equity | 3.09M | 3.31M | 9.74M | 20.3M | 29.8M | -27.3M | -22.7M | -18.4M |
| Shares outstanding | 212.0K | 1.70M | 454.2K | 8.93M | 8.73M | 936.2K | 8.21K | 8.21K |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -4.24M | -8.26M | -5.81M | -5.82M | -10.7M | -288.4K | -2.68M | -2.68M |
| Capital spending | -454 | -31.5K | -19.5K | -215.5K | -2.55K | -426 | -1.48M | -1.03M |
| Free cash flow | -4.24M | -8.30M | -5.83M | -6.03M | -10.7M | -288.8K | -4.16M | -3.71M |
| Cash from investing | -1.00M | 1.98M | -7.23M | -3.19M | -1.04M | -1.10M | -1.48M | -1.03M |
| Cash from financing | 10.2M | 5.82M | 70.9K | -3.42M | 38.7M | 2.03M | 3.08M | 3.52M |
| Share buybacks | 0 | -41 | ||||||
| Change in cash | 5.00M | -465.3K | -13.0M | -12.4M | 27.0M | 642.0K | -1.08M | -192.1K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 17, 2026 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 16, 2026 | Explanation request | SEC |
| 8-K · Current report | Nov 9, 2026 | Material contract | SEC |
| 8-K · Current report | Nov 5, 2026 | Acquisition or disposal | SEC |
| 8-K · Current report | Nov 2, 2026 | Meeting outcome | SEC |
| PRE 14A · Preliminary proxy statement | Oct 30, 2026 | Meeting notice | SEC |
| DEFR14A | Oct 19, 2026 | Meeting notice | SEC |
| PRER14A | Oct 9, 2026 | Other filings | SEC |
| 8-K · Current report | Oct 9, 2026 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | Sep 14, 2026 | Meeting notice | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Sep 10, 2026 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Sep 4, 2026 | Meeting notice | SEC |
| 8-K · Current report | Sep 4, 2026 | Material contract | SEC |
| 8-K · Current report | Aug 31, 2026 | Management or board change | SEC |
| 8-K · Current report | Aug 14, 2026 | Material contract | SEC |
| 10-Q · Quarterly report | Aug 14, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 11, 2026 | Material contract | SEC |
| 8-K · Current report | Aug 7, 2026 | Material contract | SEC |
| 424B4 · Prospectus | Aug 7, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jul 31, 2026 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jul 16, 2026 | Offer document | SEC |
| 8-K · Current report | Jul 14, 2026 | Current report | SEC |
| S-1/A · Registration statement, amended | Jul 6, 2026 | Offer document | SEC |
| S-1 · Registration statement | Jun 24, 2026 | Offer document | SEC |
| DRS/A · Draft registration statement, amended | Jun 22, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jun 18, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 15, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jun 15, 2026 | Other filings | SEC |
| S-3 · Registration statement | Jun 4, 2026 | Offer document | SEC |
| DRS · Draft registration statement | Jun 4, 2026 | Offer document | SEC |
| 8-K · Current report | Jun 1, 2026 | Current report | SEC |
| 8-K · Current report | May 29, 2026 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | May 18, 2026 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 15, 2026 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 15, 2026 | Explanation request | SEC |
| D | May 14, 2026 | Other filings | SEC |
| 8-K · Current report | May 13, 2026 | Material contract | SEC |
| 8-K · Current report | May 1, 2026 | Current report | SEC |
| 8-K · Current report | Apr 13, 2026 | Current report | SEC |
| 8-K · Current report | Apr 10, 2026 | Current report | SEC |
| 10-K · Annual report | Apr 1, 2026 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2026 | Explanation request | SEC |
| 8-K · Current report | Mar 13, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Mar 3, 2026 | Meeting notice | SEC |
| 8-K · Current report | Feb 23, 2026 | Management or board change | SEC |
| 8-K · Current report | Feb 18, 2026 | Current report | SEC |
| 8-K · Current report | Feb 6, 2026 | Current report | SEC |
| 424B3 · Prospectus | Feb 3, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Feb 2, 2026 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 28, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jan 27, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 27, 2026 | Current report | SEC |
| S-3 · Registration statement | Jan 16, 2026 | Offer document | SEC |
| 8-K/A · Current report, amended | Jan 16, 2026 | Current report | SEC |
| DEFA14A · Additional proxy material | Jan 6, 2026 | Meeting notice | SEC |
| D | Jan 5, 2026 | Other filings | SEC |
| 8-K · Current report | Jan 5, 2026 | Current report | SEC |
| 8-K · Current report | Jan 5, 2026 | Material contract | SEC |
| 8-K · Current report | Jan 2, 2026 | Material contract | SEC |
| 424B3 · Prospectus | Jan 2, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Dec 30, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Dec 23, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Dec 19, 2025 | Offer document | SEC |
| 8-K · Current report | Dec 1, 2025 | Current report | SEC |
| 8-K · Current report | Nov 21, 2025 | Current report | SEC |
| DEF 14A · Proxy statement | Nov 21, 2025 | Meeting notice | SEC |
| 3 · Initial statement of ownership | Nov 19, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 17, 2025 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 14, 2025 | Explanation request | SEC |
| PRER14A | Nov 10, 2025 | Other filings | SEC |
| 8-K · Current report | Nov 7, 2025 | Management or board change | SEC |
| PRE 14A · Preliminary proxy statement | Nov 4, 2025 | Meeting notice | SEC |
| 8-K · Current report | Nov 3, 2025 | Meeting outcome | SEC |
| S-3 · Registration statement | Oct 23, 2025 | Offer document | SEC |
| DEF 14A · Proxy statement | Oct 14, 2025 | Meeting notice | SEC |
| S-1/A · Registration statement, amended | Oct 6, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Oct 6, 2025 | Other filings | SEC |
| PRER14A | Oct 2, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Sep 22, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 8, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Sep 8, 2025 | Offer document | SEC |
| PRER14A | Sep 5, 2025 | Other filings | SEC |
| 8-K · Current report | Sep 4, 2025 | Current report | SEC |
| UPLOAD · Letter from the SEC | Aug 29, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Aug 25, 2025 | Offer document | SEC |
| 8-K · Current report | Aug 21, 2025 | Current report | SEC |
| S-1 · Registration statement | Aug 20, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| PRE 14A · Preliminary proxy statement | Aug 13, 2025 | Meeting notice | SEC |
| 8-K · Current report | Aug 7, 2025 | Current report | SEC |
| D | Aug 6, 2025 | Other filings | SEC |
| 8-K · Current report | Aug 5, 2025 | Material contract | SEC |
| 8-K · Current report | Jul 25, 2025 | Material contract | SEC |
| 424B4 · Prospectus | Jul 25, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jul 24, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 21, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 21, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 14, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 14, 2025 | Other filings | SEC |
| 8-K · Current report | Jul 10, 2025 | Current report | SEC |
| CORRESP · Letter to the SEC | Jul 10, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 10, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jul 8, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Jun 27, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jun 27, 2025 | Offer document | SEC |
| 8-K · Current report | Jun 24, 2025 | Management or board change | SEC |
| UPLOAD · Letter from the SEC | Jun 24, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jun 11, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Jun 11, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Jun 9, 2025 | Other filings | SEC |
| 8-K · Current report | Jun 5, 2025 | Current report | SEC |
| CORRESP · Letter to the SEC | May 23, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | May 23, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | May 19, 2025 | Quarterly report | SEC |
| UPLOAD · Letter from the SEC | May 16, 2025 | Other filings | SEC |
| NT 10-Q · Late filing notice | May 15, 2025 | Explanation request | SEC |
| S-1 · Registration statement | May 2, 2025 | Offer document | SEC |
| 10-K · Annual report | Apr 14, 2025 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 26, 2025 | Explanation request | SEC |
| 8-K · Current report | Mar 11, 2025 | Current report | SEC |
| 8-K/A · Current report, amended | Feb 28, 2025 | Management or board change | SEC |
| 8-K · Current report | Feb 24, 2025 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Jan 30, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 16, 2025 | Current report | SEC |
| 8-K · Current report | Dec 30, 2024 | Management or board change | SEC |
| 8-K · Current report | Dec 20, 2024 | Management or board change | SEC |
| 3 · Initial statement of ownership | Dec 13, 2024 | Insider trade | SEC |
| 8-K · Current report | Dec 13, 2024 | Current report | SEC |
| 8-K · Current report | Dec 12, 2024 | Management or board change | SEC |
| 8-K · Current report | Nov 12, 2024 | Management or board change | SEC |
| 10-Q · Quarterly report | Nov 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | Oct 31, 2024 | Material contract | SEC |
| 424B4 · Prospectus | Oct 31, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Oct 30, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 28, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Oct 28, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Oct 24, 2024 | Other filings | SEC |
| S-1 · Registration statement | Oct 18, 2024 | Offer document | SEC |
| 8-K · Current report | Oct 2, 2024 | Current report | SEC |
| 4 · Change in ownership | Sep 30, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 27, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Sep 27, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 27, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 27, 2024 | Insider trade | SEC |
| 8-K · Current report | Sep 25, 2024 | Material contract | SEC |
| 8-K · Current report | Sep 11, 2024 | Current report | SEC |
| 8-K · Current report | Aug 6, 2024 | Results | SEC |
| 10-Q · Quarterly report | Aug 6, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jul 22, 2024 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 9, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jul 8, 2024 | Management or board change | SEC |
| 8-K · Current report | Jul 3, 2024 | Material contract | SEC |
| ARS · Annual report to shareholders | Jun 10, 2024 | Annual report | SEC |
| DEF 14A · Proxy statement | Jun 10, 2024 | Meeting notice | SEC |
| PRER14A | May 28, 2024 | Other filings | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2024 | Insider trade | SEC |
| 8-K · Current report | May 17, 2024 | Current report | SEC |
| 8-K · Current report | May 7, 2024 | Results | SEC |
| 10-Q · Quarterly report | May 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | Apr 11, 2024 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Mar 28, 2024 | Meeting notice | SEC |
| 3 · Initial statement of ownership | Mar 26, 2024 | Insider trade | SEC |
| 8-K · Current report | Mar 26, 2024 | Management or board change | SEC |
| 8-K · Current report | Mar 14, 2024 | Results | SEC |
| 10-K · Annual report | Mar 13, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 5, 2024 | Material contract | SEC |
| 424B5 · Prospectus | Mar 5, 2024 | Offer document | SEC |
| 8-K · Current report | Feb 15, 2024 | Material contract | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| 5 · Annual statement of ownership | Feb 8, 2024 | Insider trade | SEC |
| 8-K · Current report | Dec 21, 2023 | Management or board change | SEC |
| 8-K · Current report | Nov 2, 2023 | Results | SEC |
| 10-Q · Quarterly report | Nov 2, 2023 | Quarterly report | SEC |
| 8-K · Current report | Oct 23, 2023 | Results | SEC |
| 8-K · Current report | Oct 10, 2023 | Current report | SEC |
| 4 · Change in ownership | Sep 15, 2023 | Insider trade | SEC |
| 8-K · Current report | Sep 6, 2023 | Current report | SEC |
| 8-K · Current report | Aug 2, 2023 | Results | SEC |
| 10-Q · Quarterly report | Aug 2, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jul 7, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Jun 1, 2023 | Insider trade | SEC |
| 8-K · Current report | May 25, 2023 | Management or board change | SEC |
| 4 · Change in ownership | May 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2023 | Insider trade | SEC |
| 8-K · Current report | May 4, 2023 | Results | SEC |
| 10-Q · Quarterly report | May 4, 2023 | Quarterly report | SEC |
| SC 13D · Big-stake notice | Apr 17, 2023 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 10, 2023 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 10, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 10, 2023 | Meeting notice | SEC |
This page holds 200 of 336 filings. Open Filings
Cap table
Built by 6ix from iSpecimen Inc.’s releases · as of Aug 6, 2026
- Common shares
- 5,789,013
- Fully diluted
- 5,789,013
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 5,789,013 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 5,789,013 |
| Nov 19, 2026 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Katharyn Field Other companies: Advasa Holdings, Inc. (Chief Financial Officer · Since at least Aug 11, 2026); BioRestorative Therapies, Inc. (Chief Executive Officer of iSpecimen Inc. (Nasdaq: ISPC) · Since at least Jun 10, 2026); LogProstyle Inc. (Director and Executive Officer, Director · Since at least Mar 18, 2026); Nuwellis, Inc. (Director · Since at least Jan 21, 2026); Virpax Pharmaceuticals, Inc. (Director · Jul 5, 2024 – Jul 5, 2024 · Past) | Board Member · Since at least Sep 25, 2024 |
| Richard Paolone Other companies: Mixed Martial Arts Group Limited (Director · Since at least Apr 22, 2025); GridAI Technologies Corp. (Interim CEO, Director · Feb 3, 2025 – Feb 3, 2025 · Past) | Director · Sep 25, 2024 – Sep 25, 2024 · Past |
| Steven R Ph D Gullans Other companies: MetaVia Inc. (Director · Aug 4, 2016 – Jan 13, 2020 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Jun 12, 2014 · Past) | Director · Jun 16, 2021 – Jan 2, 2024 · Past |
| John L Brooks Other companies: Pathfinder Cell Therapy Inc (Director · Sep 2, 2011 – Sep 2, 2011 · Past) | Director · Jun 16, 2021 – Jan 2, 2024 · Past |
| Robert Lim Other companies: AIxCrypto Holdings, Inc. (Director · Jul 12, 2024 – Jul 12, 2024 · Past) | Chief Executive Officer · Since at least Dec 9, 2024 |
| Theresa L Mock Other companies: G3 VRM Acquisition Corp (Director · Jun 30, 2021 – Jun 30, 2021 · Past) | Director · Dec 31, 2023 – Jan 2, 2024 · Past |
| Yuying Liang Other companies: Shuttle Pharmaceuticals Holdings, Inc. (Chief Financial Officer · Since at least Jan 6, 2026) | Chief Financial Officer · Dec 13, 2024 – Dec 13, 2024 · Past |
| Andrew L Ross | Director · Jun 16, 2021 – Jan 2, 2024 · Past |
| Arphing Lee | Director · Since at least Nov 7, 2025 |
| Avtar Dhaliwal | Board Member · Since at least Sep 25, 2024 |
All 18 people
| Person | Seat |
|---|---|
| Benjamin Bielak | Chief Info Officer & Secretary · Jun 16, 2021 – Sep 14, 2023 · Past |
| Christopher Ianelli | Director · Jun 16, 2021 – Jan 3, 2023 · Past |
| Elizabeth Ames Graham | Director · Mar 21, 2024 – Mar 21, 2024 · Past |
| George H Scholl | Director · Jun 16, 2021 – Jan 3, 2023 · Past |
| Jill Mullan | Director · Jun 16, 2021 – Jan 17, 2023 · Past |
| Joseph J Basile | Director · Nov 28, 2022 – Jan 3, 2023 · Past |
| Margaret H Lawrence | Director · Jun 16, 2021 – Dec 31, 2022 · Past |
| Tracy Curley | CEO, CFO and Treasurer, Director · Jun 16, 2021 – May 31, 2023 · Past |
Log in to ask 6ix AI your own questions about iSpecimen Inc.